This inventor holds 21 USPTO granted patents and 5 published patent applications and 1 EPO patent, primarily in Drug Modulators. Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp.. Active years: 2006-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (2006 - 2018)
- Ramona, CA (US) (2013 - 2024)
Company Filing History:
19 out of 2,101 
2 out of 363 
Years Active: 2006-2024
Areas of Expertise:
Title: **Innovative Contributions of Kelly J McClure in Pharmaceutical Research**
Introduction
Kelly J McClure is a prominent inventor based in San Diego, California, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 21 patents, McClure has made considerable strides in advancing medical treatments, particularly in addressing complex health conditions.
Latest Patents
Among McClure's most notable patents are the inhibitors of KEAP1-Nrf2 protein-protein interaction, specifically focusing on Sultam compounds. These innovations include pharmaceutical compositions that are effective in treating various disease states, disorders, and conditions linked to the KEAP1-Nrf2 interaction. His work provides promising methods for managing inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.
Career Highlights
Throughout his career, Kelly J McClure has been associated with leading pharmaceutical companies, including Janssen Pharmaceutica NV and Ortho-McNeil Pharmaceutical Corporation. His tenure at these firms has allowed him to leverage his expertise in drug development and research, ultimately contributing to his success as an inventor.
Collaborations
McClure has collaborated with esteemed professionals such as Michael D Hack and Alec D Lebsack. These partnerships have fostered a dynamic exchange of ideas and innovation, further enhancing McClure's contributions to the field.
Conclusion
In conclusion, Kelly J McClure's innovative work in pharmaceutical research and significant patent portfolio make him a notable figure in the industry. His dedication to developing treatments for challenging medical conditions continues to impact patient care and inspire future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile